Unnecessary use of placebo controls: The case of asthma clinical trials

Archives of Internal Medicine

Volumn 162, Issue 15, 2002, Pages 1673-1677

  Miller, Franklin G ^a   Shorr, Andrew F ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; SALBUTAMOL; SALMETEROL;

ASTHMA; CLINICAL TRIAL; DRUG SCREENING; ETHICS; HUMAN; METHODOLOGY; NOTE; PRIORITY JOURNAL;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

ADOLESCENT; ADULT; AGED; ASTHMA; CHILD; DOUBLE-BLIND METHOD; DRUG UTILIZATION; ETHICS; HELSINKI DECLARATION; HUMANS; MIDDLE AGED; PLACEBOS; TREATMENT OUTCOME;

EID: 0037067837     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.15.1673     Document Type: Note

References (25)

1. Why use placebos in clinical trials? A narrative review of the methodological literature
2. The continuing unethical use of placebo controls
3. Placebo-controlled trials in psychiatric research: An ethical perspective
4. Placebo-controlled trials and active-control trials in the evaluation of new treatments, I: Ethical and scientific issues
5. Placebo-controlled trials and active-control trials in the evaluation of new treatments, II: Practical issues and specific cases
6. Montelukast added to inhaled beclomethasone in treatment of asthma
7. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trial
8. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma
9. Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma: A randomized, double-blind, placebo-controlled trial
10. Zafirlukast for symptomatic mild-to-moderate asthma: A 13-week multicenter study
11. Placebo orthodoxy in clinical research, I: Empirical and methodological myths
12. Placebo orthodoxy in clinical research, II: Ethical, legal and regulatory myths
13. Declaration of Helsinki: Ethical principles for medical research involving human subjects
14. Declaration of Helsinki should be strengthened
15. What makes clinical research ethical?
16. Efficacy of inhaled corticosteroids in asthma
17. Antileukotrienes in the treatment of asthma
18. Long-acting beta 2-agonists: Role in primary asthma treatment
19. Placebo protects from nonresponse: A paradox of power
20. Another view of active-controlled trials
21. Active-control trials: How would a new agent compare with placebo? A method illustrated with clopidogrel, aspirin, and placebo
22. Are more antiemetic trials without a placebo necessary? Report of patient data from randomized trials of placebo antiemetics with cisplatin